ArticleMedical journal, Armed Forces India2018

A study of therapy targeted EGFR/ALK mutations in Indian patients with lung adenocarcinoma: A clinical and epidemiological study.

Vandana Rana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.